ONCODESIGN PRECISION MEDICINE financial statements, including revenue, expenses, profit, and loss
The total revenue of ALOPM for the last semiannual is 141.81 k EUR, and it's 56.62% lower compared to the previous semiannual. The net income of H1 24 is -3.64 M EUR.